Literature DB >> 24890666

Tributyrin supplementation protects mice from acute ethanol-induced gut injury.

Gail A Cresci1, Katelyn Bush, Laura E Nagy.   

Abstract

BACKGROUND: Excessive alcohol consumption leads to liver disease. Interorgan crosstalk contributes to ethanol (EtOH)-induced liver injury. EtOH exposure causes gut dysbiosis resulting in negative alterations in intestinal fermentation byproducts, particularly decreased luminal butyrate concentrations. Therefore, in the present work, we investigated the effect of butyrate supplementation, in the form of trybutyrin, as a prophylactic treatment against EtOH-induced gut injury.
METHODS: C57BL/6J mice were treated with 3 different EtOH feeding protocols: chronic feeding (25 days, 32% of kcal), short-term (2 days, 32%), or acute single gavage (5 g/kg). Tributyrin (0.83 to 10 mM) was supplemented either into the liquid diet or by oral gavage. Intestinal expression of tight junction (TJ) proteins and a butyrate receptor and transporter were evaluated, as well as liver enzymes and inflammatory markers.
RESULTS: All 3 EtOH exposure protocols reduced the expression and co-localization of TJ proteins (ZO-1, occludin) and the expression of a butyrate receptor (GPR109A) and transporter (SLC5A8) in the ileum and proximal colon. Importantly, tributyrin supplementation protected against these effects. Protection of the intestine with tributyrin supplementation was accompanied by mitigation of EtOH-induced increases in aspartate aminotransferase and inflammatory measures in the short-term and acute EtOH exposure protocols, but not after chronic EtOH feeding.
CONCLUSIONS: These findings suggest that tributyrin supplementation could serve as a prophylactic treatment against gut injury caused by short-term EtOH exposure.
Copyright © 2014 by the Research Society on Alcoholism.

Entities:  

Keywords:  Butyrate; Ethanol; Intestine; Liver; Tributyrin

Mesh:

Substances:

Year:  2014        PMID: 24890666      PMCID: PMC4185400          DOI: 10.1111/acer.12428

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  48 in total

Review 1.  Prebiotic digestion and fermentation.

Authors:  J H Cummings; G T Macfarlane; H N Englyst
Journal:  Am J Clin Nutr       Date:  2001-02       Impact factor: 7.045

2.  The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids.

Authors:  Andrew J Brown; Susan M Goldsworthy; Ashley A Barnes; Michelle M Eilert; Lili Tcheang; Dion Daniels; Alison I Muir; Mark J Wigglesworth; Ian Kinghorn; Neil J Fraser; Nicholas B Pike; Jay C Strum; Klaudia M Steplewski; Paul R Murdock; Julie C Holder; Fiona H Marshall; Philip G Szekeres; Shelagh Wilson; Diane M Ignar; Steve M Foord; Alan Wise; Simon J Dowell
Journal:  J Biol Chem       Date:  2002-12-19       Impact factor: 5.157

3.  The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line.

Authors:  M S Inan; R J Rasoulpour; L Yin; A K Hubbard; D W Rosenberg; C Giardina
Journal:  Gastroenterology       Date:  2000-04       Impact factor: 22.682

4.  Distribution of ethanol in the human gastrointestinal tract.

Authors:  C H Halsted; E A Robles; E Mezey
Journal:  Am J Clin Nutr       Date:  1973-08       Impact factor: 7.045

5.  Contrasting binge and continuous alcoholic drinkers using demographic and drinking history variables.

Authors:  G J Connors; A R Tarbox; E J McLaughlin
Journal:  Alcohol Alcohol       Date:  1986       Impact factor: 2.826

6.  Microbes and mucosa in the regulation of intracolonic acetaldehyde concentration during ethanol challenge.

Authors:  Jukka-Pekka Visapää; Jyrki Tillonen; Mikko Salaspuro
Journal:  Alcohol Alcohol       Date:  2002 Jul-Aug       Impact factor: 2.826

7.  Ethanol, the liver, and the gastrointestinal tract.

Authors:  M C Geokas; C S Lieber; S French; C H Halsted
Journal:  Ann Intern Med       Date:  1981-08       Impact factor: 25.391

Review 8.  Binge ethanol and liver: new molecular developments.

Authors:  Shivendra D Shukla; Stephen B Pruett; Gyongyi Szabo; Gavin E Arteel
Journal:  Alcohol Clin Exp Res       Date:  2013-01-24       Impact factor: 3.455

Review 9.  How host-microbial interactions shape the nutrient environment of the mammalian intestine.

Authors:  Lora V Hooper; Tore Midtvedt; Jeffrey I Gordon
Journal:  Annu Rev Nutr       Date:  2002-04-04       Impact factor: 11.848

10.  Short chain fatty acid distributions of enema samples from a sigmoidoscopy population: an association of high acetate and low butyrate ratios with adenomatous polyps and colon cancer.

Authors:  G A Weaver; J A Krause; T L Miller; M J Wolin
Journal:  Gut       Date:  1988-11       Impact factor: 23.059

View more
  51 in total

1.  Prophylactic tributyrin treatment mitigates chronic-binge ethanol-induced intestinal barrier and liver injury.

Authors:  Gail A Cresci; Bryan Glueck; Megan R McMullen; Wei Xin; Daniella Allende; Laura E Nagy
Journal:  J Gastroenterol Hepatol       Date:  2017-09       Impact factor: 4.029

Review 2.  Alcoholic liver disease: the gut microbiome and liver cross talk.

Authors:  Phillipp Hartmann; Caroline T Seebauer; Bernd Schnabl
Journal:  Alcohol Clin Exp Res       Date:  2015-05       Impact factor: 3.455

3.  Specifically Sized Hyaluronan (35 kDa) Prevents Ethanol-Induced Disruption of Epithelial Tight Junctions Through a layilin-Dependent Mechanism in Caco-2 Cells.

Authors:  Damien A Bellos; Dhara Sharma; Megan R McMullen; Jeanette Wat; Paramananda Saikia; Carol A de la Motte; Laura E Nagy
Journal:  Alcohol Clin Exp Res       Date:  2019-07-16       Impact factor: 3.455

4.  Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs.

Authors:  Zdenek Dvorak; Max Klapholz; Thomas P Burris; Benjamin P Willing; Antimo Gioiello; Roberto Pellicciari; Francesco Galli; John March; Stephen J O'Keefe; R Balfour Sartor; Chang H Kim; Maayan Levy; Sridhar Mani
Journal:  Mol Pharmacol       Date:  2020-08-06       Impact factor: 4.436

5.  Saturated and Unsaturated Dietary Fats Differentially Modulate Ethanol-Induced Changes in Gut Microbiome and Metabolome in a Mouse Model of Alcoholic Liver Disease.

Authors:  Irina A Kirpich; Joseph Petrosino; Nadim Ajami; Wenke Feng; Yuhua Wang; Yanlong Liu; Juliane I Beier; Shirish S Barve; Xinmin Yin; Xiaoli Wei; Xiang Zhang; Craig J McClain
Journal:  Am J Pathol       Date:  2016-04       Impact factor: 4.307

6.  Occludin deficiency promotes ethanol-induced disruption of colonic epithelial junctions, gut barrier dysfunction and liver damage in mice.

Authors:  Hina Mir; Avtar S Meena; Kamaljit K Chaudhry; Pradeep K Shukla; Ruchika Gangwar; Bhargavi Manda; Mythili K Padala; Le Shen; Jerrold R Turner; Paula Dietrich; Ioannis Dragatsis; RadhaKrishna Rao
Journal:  Biochim Biophys Acta       Date:  2015-12-23

7.  Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice.

Authors:  Peng Chen; Manolito Torralba; Justin Tan; Mallory Embree; Karsten Zengler; Peter Stärkel; Jan-Peter van Pijkeren; Jessica DePew; Rohit Loomba; Samuel B Ho; Jasmohan S Bajaj; Ece A Mutlu; Ali Keshavarzian; Hidekazu Tsukamoto; Karen E Nelson; Derrick E Fouts; Bernd Schnabl
Journal:  Gastroenterology       Date:  2014-09-16       Impact factor: 22.682

8.  Glucose-independent Acetate Metabolism Promotes Melanoma Cell Survival and Tumor Growth.

Authors:  Alexander J Lakhter; James Hamilton; Raymond L Konger; Nickolay Brustovetsky; Hal E Broxmeyer; Samisubbu R Naidu
Journal:  J Biol Chem       Date:  2016-08-18       Impact factor: 5.157

9.  Publisher Correction: The gut-liver axis and the intersection with the microbiome.

Authors:  Anupriya Tripathi; Justine Debelius; David A Brenner; Michael Karin; Rohit Loomba; Bernd Schnabl; Rob Knight
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-12       Impact factor: 46.802

10.  Targeting the gut barrier for the treatment of alcoholic liver disease.

Authors:  Zhanxiang Zhou; Wei Zhong
Journal:  Liver Res       Date:  2017-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.